Immune Thrombocytopenia Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: I2BA873FC5FCEN
Market Monitor Global

Abstracts

Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.

This report contains market size and forecasts of Immune Thrombocytopenia Drugs in Global, including the following market information:

Global Immune Thrombocytopenia Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Immune Thrombocytopenia Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Thrombopoietin Receptor Agonists (TPO-RAs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Immune Thrombocytopenia Drugs include Amgen Inc., CSL Ltd., Horizon Therapeutics Plc, Merck & Co., Inc., Novartis AG and Rigel Pharmaceuticals Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immune Thrombocytopenia Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immune Thrombocytopenia Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Immune Thrombocytopenia Drugs Market Segment Percentages, by Type, 2021 (%)

• Thrombopoietin Receptor Agonists (TPO-RAs)
• Corticosteroids
• Intravenous Immunoglobins (IVIGs)
• Other Drugs

Global Immune Thrombocytopenia Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Immune Thrombocytopenia Drugs Market Segment Percentages, by Application, 2021 (%)

• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostic Centers
• Academic Institutes and Research Organizations

Global Immune Thrombocytopenia Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Immune Thrombocytopenia Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Immune Thrombocytopenia Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Immune Thrombocytopenia Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen Inc.
• CSL Ltd.
• Horizon Therapeutics Plc
• Merck & Co., Inc.
• Novartis AG
• Rigel Pharmaceuticals Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Immune Thrombocytopenia Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Immune Thrombocytopenia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IMMUNE THROMBOCYTOPENIA DRUGS OVERALL MARKET SIZE

2.1 Global Immune Thrombocytopenia Drugs Market Size: 2021 VS 2028
2.2 Global Immune Thrombocytopenia Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Immune Thrombocytopenia Drugs Players in Global Market
3.2 Top Global Immune Thrombocytopenia Drugs Companies Ranked by Revenue
3.3 Global Immune Thrombocytopenia Drugs Revenue by Companies
3.4 Top 3 and Top 5 Immune Thrombocytopenia Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Immune Thrombocytopenia Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immune Thrombocytopenia Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Immune Thrombocytopenia Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Immune Thrombocytopenia Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Immune Thrombocytopenia Drugs Market Size Markets, 2021 & 2028
  4.1.2 Thrombopoietin Receptor Agonists (TPO-RAs)
  4.1.3 Corticosteroids
  4.1.4 Intravenous Immunoglobins (IVIGs)
  4.1.5 Other Drugs
4.2 By Type - Global Immune Thrombocytopenia Drugs Revenue & Forecasts
  4.2.1 By Type - Global Immune Thrombocytopenia Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Immune Thrombocytopenia Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Immune Thrombocytopenia Drugs Market Size, 2021 & 2028
  5.1.2 Biotechnology and Pharmaceutical Companies
  5.1.3 Hospitals and Diagnostic Centers
  5.1.4 Academic Institutes and Research Organizations
5.2 By Application - Global Immune Thrombocytopenia Drugs Revenue & Forecasts
  5.2.1 By Application - Global Immune Thrombocytopenia Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Immune Thrombocytopenia Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Immune Thrombocytopenia Drugs Market Size, 2021 & 2028
6.2 By Region - Global Immune Thrombocytopenia Drugs Revenue & Forecasts
  6.2.1 By Region - Global Immune Thrombocytopenia Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Immune Thrombocytopenia Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Immune Thrombocytopenia Drugs Revenue, 2017-2028
  6.3.2 US Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.3.3 Canada Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.3.4 Mexico Immune Thrombocytopenia Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Immune Thrombocytopenia Drugs Revenue, 2017-2028
  6.4.2 Germany Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.4.3 France Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.4.4 U.K. Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.4.5 Italy Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.4.6 Russia Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.4.8 Benelux Immune Thrombocytopenia Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Immune Thrombocytopenia Drugs Revenue, 2017-2028
  6.5.2 China Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.5.3 Japan Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.5.4 South Korea Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.5.6 India Immune Thrombocytopenia Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Immune Thrombocytopenia Drugs Revenue, 2017-2028
  6.6.2 Brazil Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.6.3 Argentina Immune Thrombocytopenia Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Immune Thrombocytopenia Drugs Revenue, 2017-2028
  6.7.2 Turkey Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.7.3 Israel Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Immune Thrombocytopenia Drugs Market Size, 2017-2028
  6.7.5 UAE Immune Thrombocytopenia Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen Inc.
  7.1.1 Amgen Inc. Corporate Summary
  7.1.2 Amgen Inc. Business Overview
  7.1.3 Amgen Inc. Immune Thrombocytopenia Drugs Major Product Offerings
  7.1.4 Amgen Inc. Immune Thrombocytopenia Drugs Revenue in Global Market (2017-2022)
  7.1.5 Amgen Inc. Key News
7.2 CSL Ltd.
  7.2.1 CSL Ltd. Corporate Summary
  7.2.2 CSL Ltd. Business Overview
  7.2.3 CSL Ltd. Immune Thrombocytopenia Drugs Major Product Offerings
  7.2.4 CSL Ltd. Immune Thrombocytopenia Drugs Revenue in Global Market (2017-2022)
  7.2.5 CSL Ltd. Key News
7.3 Horizon Therapeutics Plc
  7.3.1 Horizon Therapeutics Plc Corporate Summary
  7.3.2 Horizon Therapeutics Plc Business Overview
  7.3.3 Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Major Product Offerings
  7.3.4 Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Revenue in Global Market (2017-2022)
  7.3.5 Horizon Therapeutics Plc Key News
7.4 Merck & Co., Inc.
  7.4.1 Merck & Co., Inc. Corporate Summary
  7.4.2 Merck & Co., Inc. Business Overview
  7.4.3 Merck & Co., Inc. Immune Thrombocytopenia Drugs Major Product Offerings
  7.4.4 Merck & Co., Inc. Immune Thrombocytopenia Drugs Revenue in Global Market (2017-2022)
  7.4.5 Merck & Co., Inc. Key News
7.5 Novartis AG
  7.5.1 Novartis AG Corporate Summary
  7.5.2 Novartis AG Business Overview
  7.5.3 Novartis AG Immune Thrombocytopenia Drugs Major Product Offerings
  7.5.4 Novartis AG Immune Thrombocytopenia Drugs Revenue in Global Market (2017-2022)
  7.5.5 Novartis AG Key News
7.6 Rigel Pharmaceuticals Inc.
  7.6.1 Rigel Pharmaceuticals Inc. Corporate Summary
  7.6.2 Rigel Pharmaceuticals Inc. Business Overview
  7.6.3 Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Major Product Offerings
  7.6.4 Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Revenue in Global Market (2017-2022)
  7.6.5 Rigel Pharmaceuticals Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Immune Thrombocytopenia Drugs Market Opportunities & Trends in Global Market
Table 2. Immune Thrombocytopenia Drugs Market Drivers in Global Market
Table 3. Immune Thrombocytopenia Drugs Market Restraints in Global Market
Table 4. Key Players of Immune Thrombocytopenia Drugs in Global Market
Table 5. Top Immune Thrombocytopenia Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Immune Thrombocytopenia Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Immune Thrombocytopenia Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Immune Thrombocytopenia Drugs Product Type
Table 9. List of Global Tier 1 Immune Thrombocytopenia Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Thrombocytopenia Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Immune Thrombocytopenia Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Immune Thrombocytopenia Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Immune Thrombocytopenia Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Immune Thrombocytopenia Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Immune Thrombocytopenia Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Immune Thrombocytopenia Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Inc. Corporate Summary
Table 31. Amgen Inc. Immune Thrombocytopenia Drugs Product Offerings
Table 32. Amgen Inc. Immune Thrombocytopenia Drugs Revenue (US$, Mn), (2017-2022)
Table 33. CSL Ltd. Corporate Summary
Table 34. CSL Ltd. Immune Thrombocytopenia Drugs Product Offerings
Table 35. CSL Ltd. Immune Thrombocytopenia Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Horizon Therapeutics Plc Corporate Summary
Table 37. Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Product Offerings
Table 38. Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co., Inc. Corporate Summary
Table 40. Merck & Co., Inc. Immune Thrombocytopenia Drugs Product Offerings
Table 41. Merck & Co., Inc. Immune Thrombocytopenia Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Immune Thrombocytopenia Drugs Product Offerings
Table 44. Novartis AG Immune Thrombocytopenia Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Rigel Pharmaceuticals Inc. Corporate Summary
Table 46. Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Product Offerings
Table 47. Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Immune Thrombocytopenia Drugs Segment by Type in 2021
Figure 2. Immune Thrombocytopenia Drugs Segment by Application in 2021
Figure 3. Global Immune Thrombocytopenia Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immune Thrombocytopenia Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immune Thrombocytopenia Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immune Thrombocytopenia Drugs Revenue in 2021
Figure 8. By Type - Global Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028
Figure 12. US Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028
Figure 24. China Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Immune Thrombocytopenia Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Immune Thrombocytopenia Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Inc. Immune Thrombocytopenia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. CSL Ltd. Immune Thrombocytopenia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co., Inc. Immune Thrombocytopenia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis AG Immune Thrombocytopenia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)